Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression
- 18 September 2010
- journal article
- research article
- Published by Elsevier BV in Regulatory Peptides
- Vol. 166 (1-3), 90-97
- https://doi.org/10.1016/j.regpep.2010.09.005
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- New standards in hypertension and cardiovascular risk management: focus on telmisartanVascular Health and Risk Management, 2010
- Actin polymerization in differentiated vascular smooth muscle cells requires vasodilator-stimulated phosphoproteinAmerican Journal of Physiology-Cell Physiology, 2010
- Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2Hypertension, 2010
- Telmisartan-Induced Inhibition of Vascular Cell Proliferation Beyond Angiotensin Receptor Blockade and Peroxisome Proliferator-Activated Receptor-γ ActivationHypertension, 2009
- Human Recombinant ACE2 Reduces the Progression of Diabetic NephropathyDiabetes, 2009
- ACE2 is expressed in mouse adipocytes and regulated by a high-fat dietAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expressionBritish Journal of Pharmacology, 2008
- Control of the Assembly of ATP- and ADP-Actin by Formins and ProfilinCell, 2006
- Upregulation of Angiotensin-Converting Enzyme 2 by All- trans Retinoic Acid in Spontaneously Hypertensive RatsHypertension, 2004
- Molecular Mechanisms of Inhibition of Vascular Growth by Angiotensin-(1-7)Hypertension, 2003